Evidence map›Paper›PMID 25826722›Full record

ArticleCellular reprogramming2015

Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation.

Z Elizabeth Floyd, Elizabeth Z Floyd, Jaroslaw Staszkiewicz, Rachel A Power, Gail Kilroy, Heather Kirk-Ballard, Christian W Barnes, Karen L Strickler, Jong S Rim, Lettie L Harkins and 3 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Cellular reprogramming, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Z Elizabeth Floyd
Elizabeth Z Floyd1 Ubiquitin Lab, Pennington Biomedical Research Center, Louisiana State University System , Baton Rouge, LA, 70803.
Jaroslaw Staszkiewicz
Rachel A Power
Gail Kilroy
Heather Kirk-Ballard
Christian W Barnes
Karen L Strickler
Jong S Rim
Lettie L Harkins
Ru Gao
Jeong Kim
Kenneth J Eilertsen
NuPotential (United States) · USPennington Biomedical Research Center · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leanne Maree Redman · 2005 to 2026
$26.5M
Mentoring Obesity and Diabetes Research in LouisianaP20GM103528 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2012 to 2015
$8.8M
Improving Epigenetic-based Cell Reprogramming with Proteasome InhibitionR41RR031430 · NCRR · NUPOTENTIAL, INC. · PI FLOYD, ZELPHA ELIZABETH, STASZKIEWICZ, JAROSLAW · 2010 to 2011
$329k
NCRR NIH HHS 1R41RR031430NCRR NIH HHS R41 RR031430NIDDK NIH HHS 2P30-DK072476NIDDK NIH HHS P30 DK072476NIGMS NIH HHS 8P20-GM103528
6 · The paper itself

Abstract

There is ample evidence that the ubiquitin-proteasome system is an important regulator of transcription and its activity is necessary for maintaining pluripotency and promoting cellular reprogramming. Moreover, proteasome activity contributes to maintaining the open chromatin structure found in pluripotent stem cells, acting as a transcriptional inhibitor at specific gene loci generally associated with differentiation. The current study was designed to understand further the role of proteasome inhibition in reprogramming and its ability to modulate endogenous expression of pluripotency-related genes and induced pluripotent stem cells (iPSCs) colony formation. Herein, we demonstrate that acute combinatorial treatment with the proteasome inhibitors MG101 or MG132 and the histone deacetylase (HDAC) inhibitor valproic acid (VPA) increases gene expression of the pluripotency marker Oct3/4, and that MG101 alone is as effective as VPA in the induction of Oct3/4 mRNA expression in fibroblasts. Prolonged proteasome inhibition cyclically upregulates gene expression of Oct3/4 and Nanog, but reduces colony formation in the presence of the iPSC induction cocktail. In conclusion, our results demonstrate that the 26S proteasome is an essential modulator in the reprogramming process. Its inhibition enhances expression of pluripotency-related genes; however, efficient colony formation requires proteasome activity. Therefore, discovery of small molecules that increase proteasome activity might lead to more efficient cell reprogramming and generation of pluripotent cells.

Indexed as

Cell DifferentiationCells, CulturedCellular ReprogrammingFibroblastsGene Expression RegulationHomeodomain ProteinsHumansInduced Pluripotent Stem CellsLeupeptinsNanog Homeobox ProteinOctamer Transcription Factor-3OligopeptidesProteasome Endopeptidase ComplexProteasome InhibitorsTranscriptional ActivationUp-RegulationATP dependent 26S proteasebenzyloxycarbonylleucyl-leucyl-leucine aldehydeHomeodomain ProteinsLeupeptinsN-acetylleucyl-leucyl-norleucineNanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3OligopeptidesPOU5F1 protein, humanProteasome Endopeptidase ComplexProteasome InhibitorsValproic Acid

Identifiers

PMID25826722
PMCPMC4378358
OpenAlexW2128646590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.